Suspected clopidogrel-associated hepatitis in a cat

Astrid L Kamp1, Washma Yousofzai2, Hans S Kooistra1

  • 1Department Clinical Sciences, Division Internal Medicine of Companion Animals, Utrecht University, Utrecht, The Netherlands.

JFMS Open Reports
|November 8, 2024
PubMed

Insights

Acute hepatitis is a potential adverse effect of clopidogrel in cats with cardiomyopathy. Veterinarians should monitor feline patients for liver damage during clopidogrel treatment.

Area of Science:

  • Veterinary Medicine
  • Pharmacology
  • Hepatology

Background:

  • Clopidogrel is commonly used to treat feline cardiomyopathies.
  • The safety and adverse effects of clopidogrel in cats are not well-documented.
  • Limited studies exist on clopidogrel's adverse effects in feline patients.

Observation:

  • A 6-year-old castrated male cat with hypertrophic cardiomyopathy phenotype was treated with clopidogrel.
  • The cat developed signs of acute hepatitis after 5 weeks of treatment.
  • This case highlights a potential adverse reaction to clopidogrel in cats.

Findings:

  • Acute hepatitis is a rare but potential adverse effect of clopidogrel in cats.
  • Hepatotoxicity should be considered in feline patients experiencing clinical deterioration while on clopidogrel therapy.
  • This case contributes to the limited literature on clopidogrel's safety profile in veterinary medicine.

Implications:

  • Veterinarians should be aware of the potential for clopidogrel-induced hepatotoxicity in cats.
  • Monitoring liver function in cats receiving clopidogrel is recommended.
  • Further research is needed to fully understand the risks and benefits of clopidogrel in feline patients.
Abstract